| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.2 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.08 |